This global killer is fuelled by poverty – and in turn is a major threat to development, devastating family and community efforts to build better lives. Three-quarters of infected people go without the drug treatments that could help them. Latest02 February 2008JOHANNESBURG, South Africa (2 February, 2008) - Kristin Davis, star of US hit TV show Sex & the City, joined Oxfam and leading AIDS activists at a Johannesburg press conference today, to support community efforts in addressing the HIV and AIDS epidemic in South Africa.
01 December 2007Today, on World AIDS Day, Oxfam Global Ambassador Annie Lennox is launching SING, a new charity single calling on women to 'sing out' around the issues of HIV and AIDS. Featuring the vocal talents of 23 major female artists, including Angelique Kidjo, Madonna, Melissa Etheridge, Dido, Pink, Shakira, Fergie and Céline Dion, the single is aimed at raising international awareness of the impact of HIV and AIDS in South Africa, particularly the epidemic's toll on women and children. Money raised by the single will go to Oxfam partner, Treatment Action Campaign, a South African HIV and AIDS organization.
28 November 2007A huge boost in the numbers of health workers is urgently needed as millions of HIV and AIDS patients continue to be left without proper care, according to international aid agency Oxfam. As part of its campaign calling for better essential services like health care, Oxfam calls on rich countries to lead the fight against the pandemic by fully funding the Global Fund for AIDS, Tuberculosis and Malaria, and supporting poor countries to build their health systems, including the recruitment, training and retention of more health workers.
27 November 2007The pharmaceutical industry is denying medicines to millions of poor people and undermining its own future because companies are refusing to change the way they do business in developing country markets. Oxfam’s report, "Investing for Life", says that companies are still not investing enough into researching and developing medicines for diseases that predominantly affect poor people in developing countries.
|
|
|||
 |
|||
|
|||
|
|||
|
|||
|
|||
|
|||
|
|||
Article from Oxfam International:
http://www.oxfam.org/en/programs/campaigns/health_and_education/aids/index.htm
Published:
30
November
2005
